Mycotopia Therapies Inc (TPIA)
0.04
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Mycotopia Therapies Shareholders Equity (Quarterly): -2.454M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -2.454M |
December 31, 2023 | -2.028M |
September 30, 2023 | -1.737M |
June 30, 2023 | -1.429M |
March 31, 2023 | -1.194M |
December 31, 2022 | -0.8913M |
September 30, 2022 | -0.2352M |
June 30, 2022 | 0.2728M |
March 31, 2022 | 0.5261M |
December 31, 2021 | 0.052M |
September 30, 2021 | 0.2339M |
Date | Value |
---|---|
June 30, 2021 | -0.1319M |
March 31, 2021 | -0.0245M |
December 31, 2020 | -0.0162M |
September 30, 2020 | 0.4836M |
June 30, 2020 | 0.5377M |
March 31, 2020 | 0.6093M |
December 31, 2019 | 0.6519M |
September 30, 2019 | 0.7448M |
June 30, 2019 | 0.7009M |
December 31, 2018 | 0.6471M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.454M
Minimum
Mar 2024
0.7448M
Maximum
Sep 2019
-0.2665M
Average
0.0179M
Median
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 14.30M |
AIM ImmunoTech Inc | 4.826M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 0.16M |
Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.145M |
Total Liabilities (Quarterly) | 4.599M |